If you need more lookups,
subscriptions start at $34 USD/month.
Peter Melnyk Location
Cold Spring Harbor, NY, US
Peter Melnyk Work
President and CEO @ (January 2026 - Present)
Chief Commercial Officer @ (September 2022 - January 2026)
Member Board Of Directors @ (December 2020 - September 2022)
CEO @ (June 2019 - September 2022)
Principal @ Targeted pathways (January 2018 - May 2019)
Chief Commercial Officer @ Novocure (September 2011 - December 2017)
Sr. VP. Global Sales and Marketing @ OSI Pharma / Astellas Pharma US (June 2005 - June 2011)
VP, Global Oncology Commercial Planning @ OSI Pharmaceuticals Inc (September 2003 - June 2005)
exec director Oncology @ (January 2003 - December 2003)
Exec. Director, Oncology @ (January 2000 - January 2003)
exec director Oncology @ Pharmacia/Pfizer (January 2000 - December 2003)
Oncology @ (January 1991 - December 2000)
Peter Melnyk Education
McGill University 1982-1998
Peter Melnyk Skills
Biotechnology
Osi
Clinical Development
Biopharmaceuticals
Peter Melnyk Summary
Peter Melnyk, based in Cold Spring Harbor, NY, US, is currently a President and CEO at Taiho Oncology, Inc.. Peter Melnyk brings experience from previous roles at Alpha Tau Medical, Fortovia Therapeutics and Targeted pathways. Peter Melnyk holds a 1982 - 1998 McGill University. With a robust skill set that includes Biotechnology, Osi, Clinical Development, Biopharmaceuticals and more. Peter Melnyk has 3 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Peter Melnyk?
Find contact details for 700 million professionals.